Documentos de Stute P. | REDI

Regresar

Mostrando 10 resultados de: 13

Filtros aplicados

Publisher: "Maturitas"

Subtipo de publicación

Área temáticas

Ginecología, obstetricia, pediatría, geriatría(9)

Enfermedades(7)

Salud y seguridad personal(6)

Farmacología y terapéutica(3)

Fisiología humana(3)

Área de conocimiento

Ginecología(4)

Medicina interna(2)

Estudios de género(1)

Año de Publicación

Origen

Palabras Claves

Bisphosphonates(2)

Early menopause(2)

Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.

Palabras claves:

Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.

A model of care for healthy menopause and ageing: EMAS position statement

Abstract: Worldwide, the number of menopausal women is increasing. They present with complex medical issues th

Palabras claves:

EMAS, Healthcare model, Healthy menopause, Holistic, Women's health

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., van der Schouw Y.T.

Current management of pelvic organ prolapse in aging women: EMAS clinical guide

Abstract: Management of pelvic organ prolapse (POP) is a common and challenging task. Nowadays older women are

Palabras claves:

aging, management, Pelvic organ prolapse, Urinary incontinence

Cano A., Giannini A., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Russo E., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.

Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide

Abstract: Introduction Postmenopausal osteoporosis is a highly prevalent disease. Prevention through lifestyle

Palabras claves:

calcium, diet, Excess-calcium risk, Postmenopausal osteoporosis, prevention

Cano A., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.

EMAS position statement: Pbkp_redictors of premature and early natural menopause

Abstract: Introduction: While the associations of genetic, reproductive and environmental factors with the tim

Palabras claves:

Aetiology, Early menopause, Premature ovarian insufficiency, RISK FACTORS

Cano A., Chung H.F., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.

EMAS position statement: Testosterone replacement therapy in the aging male

Abstract: Introduction Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, chara

Palabras claves:

Aging male, Late-onset hypogonadism, Testosterone replacement

Ceausu I., Depypere H., Dimopoulou C., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simonsini T., Stevenson J.C., Stute P., van der Schouw Y.T.

EMAS recommendations for conditions in the workplace for menopausal women

Abstract: Women form a large part of many workforces throughout Europe. Many will be working throughout their

Palabras claves:

MENOPAUSE, Women, workplace

Ceausu I., Depypere H., Faustino R. Pérez-López, Griffiths A., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., van der Schouw Y.T.

Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement

Abstract: Background Bisphosphonates and denosumab are used extensively in the treatment of postmenopausal ost

Palabras claves:

Alendronate, Bisphosphonates, Denosumab, Drug holiday, Risedronate, Zoledronic acid

Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.

Osteoporosis management in patients with breast cancer: EMAS position statement

Abstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog

Palabras claves:

adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screening

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.

Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS)

Abstract: This position statement from the European Menopause and Andropause Society (EMAS) provides a care pa

Palabras claves:

genitourinary syndrome of menopause, hormone therapy, Hot Flushes, MENOPAUSE, OSTEOPOROSIS, Women

Armeni E., Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Schouw Y.T.V.D., Senturk L.M., Simoncini T., Stevenson J.C., Stute P.